Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment
- PMID: 12793895
- PMCID: PMC165004
- DOI: 10.1186/bcr589
Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment
Abstract
Growth and progression of breast cancers are accompanied by increased neovascularization (angiogenesis). A variety of factors, including hypoxia and genetic changes in the tumor cells, contribute to increased production of angiogenic factors. Furthermore, cells within the activated tumor stroma also contribute to the increase in production of vascular endothelial growth factor and other angiogenic factors, including basic fibroblast growth factor and platelet-derived growth factor. The contribution of the microenvironment to tumor-induced angiogenesis is underscored by findings that breast tumors implanted into different tissue sites show marked differences in the extent and nature of the angiogenic response. These findings have important implications for designing anti-angiogenic therapies.
Similar articles
-
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.Cancer Res. 1997 Mar 1;57(5):963-9. Cancer Res. 1997. PMID: 9041202
-
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.Am J Pathol. 2003 Jun;162(6):1913-26. doi: 10.1016/S0002-9440(10)64325-8. Am J Pathol. 2003. PMID: 12759248 Free PMC article.
-
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677
-
The role of angiogenic growth factors in breast cancer progression.Cancer Metastasis Rev. 1996 Jun;15(2):213-9. doi: 10.1007/BF00437474. Cancer Metastasis Rev. 1996. PMID: 8842493 Review. No abstract available.
-
Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.Semin Oncol. 2002 Jun;29(3 Suppl 11):104-10. doi: 10.1053/sonc.2002.34062. Semin Oncol. 2002. PMID: 12138404 Review.
Cited by
-
Erianin inhibits cell migration and induces apoptosis by inhibiting VEGF-α/PI3K/AKT signaling pathway in malignant melanoma.Sci Rep. 2025 May 6;15(1):15766. doi: 10.1038/s41598-025-99383-0. Sci Rep. 2025. PMID: 40328945 Free PMC article.
-
Paper-based in vitro tissue chip for delivering programmed mechanical stimuli of local compression and shear flow.J Biol Eng. 2020 Jul 28;14:20. doi: 10.1186/s13036-020-00242-5. eCollection 2020. J Biol Eng. 2020. PMID: 32742306 Free PMC article.
-
MicroRNAs: A Link between Mammary Gland Development and Breast Cancer.Int J Mol Sci. 2022 Dec 15;23(24):15978. doi: 10.3390/ijms232415978. Int J Mol Sci. 2022. PMID: 36555616 Free PMC article. Review.
-
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.Clin Exp Metastasis. 2004;21(6):525-33. doi: 10.1007/s10585-004-3503-x. Clin Exp Metastasis. 2004. PMID: 15679050
-
CCN1 promotes vascular endothelial growth factor secretion through αvβ 3 integrin receptors in breast cancer.J Cell Commun Signal. 2014 Mar;8(1):23-7. doi: 10.1007/s12079-013-0214-6. Epub 2013 Dec 12. J Cell Commun Signal. 2014. PMID: 24338441 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical